168 related articles for article (PubMed ID: 7931358)
21. Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.
Ramsay RR; Krueger MJ; Youngster SK; Gluck MR; Casida JE; Singer TP
J Neurochem; 1991 Apr; 56(4):1184-90. PubMed ID: 2002336
[TBL] [Abstract][Full Text] [Related]
22. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
23. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
25. Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation.
McNaught KS; Jenner P
Biochem Pharmacol; 2000 Oct; 60(7):979-88. PubMed ID: 10974207
[TBL] [Abstract][Full Text] [Related]
26. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
27. Neuroscience. Pesticide causes Parkinson's in rats.
Helmuth L
Science; 2000 Nov; 290(5494):1068. PubMed ID: 11184997
[No Abstract] [Full Text] [Related]
28. Apoptosis in neurodegenerative disorders.
Mochizuki H; Mori H; Mizuno Y
J Neural Transm Suppl; 1997; 50():125-40. PubMed ID: 9120413
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells.
Watabe M; Nakaki T
J Pharmacol Exp Ther; 2007 Nov; 323(2):499-507. PubMed ID: 17726156
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial dysfunction in Parkinson's disease.
Greenamyre JT; MacKenzie G; Peng TI; Stephans SE
Biochem Soc Symp; 1999; 66():85-97. PubMed ID: 10989660
[TBL] [Abstract][Full Text] [Related]
31. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease.
Jha N; Jurma O; Lalli G; Liu Y; Pettus EH; Greenamyre JT; Liu RM; Forman HJ; Andersen JK
J Biol Chem; 2000 Aug; 275(34):26096-101. PubMed ID: 10846169
[TBL] [Abstract][Full Text] [Related]
32. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease.
Ryu EJ; Harding HP; Angelastro JM; Vitolo OV; Ron D; Greene LA
J Neurosci; 2002 Dec; 22(24):10690-8. PubMed ID: 12486162
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity.
Ying R; Liang HL; Whelan HT; Eells JT; Wong-Riley MT
Brain Res; 2008 Dec; 1243():167-73. PubMed ID: 18848925
[TBL] [Abstract][Full Text] [Related]
34. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
[TBL] [Abstract][Full Text] [Related]
35. Cell death caused by the synergistic effects of zinc and dopamine is mediated by a stress sensor gene Gadd45b - implication in the pathogenesis of Parkinson's disease.
Yang TC; Wu PC; Chung IF; Jiang JH; Fann MJ; Kao LS
J Neurochem; 2016 Oct; 139(1):120-33. PubMed ID: 27385273
[TBL] [Abstract][Full Text] [Related]
36. Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease.
Murtaza M; Shan J; Matigian N; Todorovic M; Cook AL; Ravishankar S; Dong LF; Neuzil J; Silburn P; Mackay-Sim A; Mellick GD; Wood SA
PLoS One; 2016; 11(4):e0154544. PubMed ID: 27123847
[TBL] [Abstract][Full Text] [Related]
37. Lipophilic Cationic Cyanines Are Potent Complex I Inhibitors and Specific in Vitro Dopaminergic Toxins with Mechanistic Similarities to Both Rotenone and MPP(.).
Kadigamuwa CC; Mapa MS; Wimalasena K
Chem Res Toxicol; 2016 Sep; 29(9):1468-79. PubMed ID: 27510327
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
[TBL] [Abstract][Full Text] [Related]
39. Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells.
Seyfried J; Soldner F; Kunz WS; Schulz JB; Klockgether T; Kovar KA; Wüllner U
Neurochem Int; 2000 May; 36(6):489-97. PubMed ID: 10762085
[TBL] [Abstract][Full Text] [Related]
40. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
Lamensdorf I; Eisenhofer G; Harvey-White J; Nechustan A; Kirk K; Kopin IJ
Brain Res; 2000 Jun; 868(2):191-201. PubMed ID: 10854571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
